Literature DB >> 17557900

Racial differences in serum selenium concentration: analysis of US population data from the Third National Health and Nutrition Examination Survey.

Tara M Vogt1, Regina G Ziegler, Blossom H Patterson, Barry I Graubard.   

Abstract

Lower intake of the essential trace element selenium may be a risk factor for prostate cancer and other cancers. In the United States, many racial disparities in cancer incidence, such as the 61% higher incidence of prostate cancer among Blacks relative to Whites, remain unexplained. Using data from a large, nationally representative survey, the authors explored Black/White differences in serum selenium concentration. Mean serum selenium concentrations, both crude and adjusted for known predictors of serum selenium, were determined for 10,779 Black and White males and females aged >or=12 years who participated in the Third National Health and Nutrition Examination Survey (1988-1994). Crude mean serum selenium concentrations were 126.35 ng/ml for Whites and 118.76 ng/ml (approximately 6% lower) for Blacks. Adjustment for known serum selenium predictors, including a proxy for residence at the county level, reduced the racial disparity, although concentrations remained approximately 3% lower in Blacks than in Whites of both sexes (p<0.0001). The observation that Blacks had lower unadjusted and adjusted serum selenium concentrations relative to Whites is intriguing, given the racial disparity in incidence of prostate cancer and other cancers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17557900     DOI: 10.1093/aje/kwm075

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  15 in total

1.  Selenium-responsive proteins in the sera of selenium-enriched yeast-supplemented healthy African American and Caucasian men.

Authors:  Raghu Sinha; Indu Sinha; Nicole Facompre; Stephen Russell; Richard I Somiari; John P Richie; Karam El-Bayoumy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-19       Impact factor: 4.254

2.  Selenomethionine and alpha-tocopherol do not inhibit prostate carcinogenesis in the testosterone plus estradiol-treated NBL rat model.

Authors:  Nur Ozten; Lori Horton; Salamia Lasano; Maarten C Bosland
Journal:  Cancer Prev Res (Phila)       Date:  2010-02-23

3.  Trace elements and vitamin E status in Nigerian patients with prostate cancer.

Authors:  O A Adaramoye; O Akinloye; I K Olatunji
Journal:  Afr Health Sci       Date:  2010-03       Impact factor: 0.927

4.  Distribution of toenail selenium levels in young adult Caucasians and African Americans in the United States: the CARDIA Trace Element Study.

Authors:  Pengcheng Xun; Deborah Bujnowski; Kiang Liu; J Steve Morris; Zhongqin Guo; Ka He
Journal:  Environ Res       Date:  2011-02-11       Impact factor: 6.498

5.  Association of selenium status and blood glutathione concentrations in blacks and whites.

Authors:  John P Richie; Joshua E Muscat; Irina Ellison; Ana Calcagnotto; Wayne Kleinman; Karam El-Bayoumy
Journal:  Nutr Cancer       Date:  2011       Impact factor: 2.900

6.  Differential effects of selenium on benign and malignant prostate epithelial cells: stimulation of LNCaP cell growth by noncytotoxic, low selenite concentrations.

Authors:  Nur Ozten Kandaş; Carla Randolph; Maarten C Bosland
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

7.  Selenium level is associated with apoE epsilon4 in rural elderly Chinese.

Authors:  Sujuan Gao; Yinlong Jin; Kathleen S Hall; Chaoke Liang; Frederick W Unverzagt; Feng Ma; Yibin Cheng; Jianzhao Shen; Jingxiang Cao; Janetta Matesan; Ping Li; Jianchao Bian; Hugh C Hendrie; Jill R Murrell
Journal:  Public Health Nutr       Date:  2009-03-12       Impact factor: 4.022

8.  Lung cancer risk associated with selenium status is modified in smoking individuals by Sep15 polymorphism.

Authors:  Ewa Jablonska; Jolanta Gromadzinska; Wojciech Sobala; Edyta Reszka; Wojciech Wasowicz
Journal:  Eur J Nutr       Date:  2008-01-31       Impact factor: 5.614

9.  Plasma selenium measurements in subjects from areas with contrasting gastric cancer risks in Colombia.

Authors:  M Constanza Camargo; Raymond F Burk; Luis E Bravo; M Blanca Piazuelo; Kristina E Hill; Elizabeth T H Fontham; Amy K Motley; Maria Clara Yepez; Yolanda Mora; Barbara G Schneider; Pelayo Correa
Journal:  Arch Med Res       Date:  2008-03-10       Impact factor: 2.235

10.  Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer.

Authors:  Yanfeng Qi; Xueqi Fu; Zhenggang Xiong; Haitao Zhang; Steven M Hill; Brian G Rowan; Yan Dong
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.